Prevention and treatment of venous thromboembolism in older people

Reviews in Clinical Gerontology

Volumn 18, Issue 3, 2008, Pages 219-228

  Veiraiah, A ^a,c   Shetty, H G M ^a   Routledge, P A ^b  

^a CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; COUMARIN; DABIGATRAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; IDRAPARINUX; LOW MOLECULAR WEIGHT HEPARIN; RIVAROXABAN; SSR 126517; UNCLASSIFIED DRUG; WARFARIN;

CLINICAL TRIAL; COMPRESSION GARMENT; DEEP VEIN THROMBOSIS; DRUG DOSE REDUCTION; GERIATRIC PATIENT; HOSPITAL PATIENT; HUMAN; LOW DRUG DOSE; MEDICAL SPECIALIST; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SURGICAL PATIENT; VENOUS THROMBOEMBOLISM;

EID: 69749117755     PISSN: 09592598     EISSN: 14699036     Source Type: Journal    
DOI: 10.1017/S0959259809002871     Document Type: Review

References (77)

1. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 861-866 (Pubitemid 24135768)
2. Chang KP, Center JR, Nguyen TV, Eisman JA. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 2004; 19: 532-536
3. Girasole GJ, Cuomo F, Denton JR, O'Connor D, Ernst A. Diagnosis of deep vein thrombosis in elderly hip-fracture patients by using the duplex scanning technique. Orthop Rev 1994; 23: 411-416 (Pubitemid 24166906)
4. Lawall H, Hoffmanns W, Hoffmanns P et al. Prevalence of deep vein thrombosis (DVT) in non-surgical patients at hospital admission. Thromb Haemost 2007; 98: 765-770 (Pubitemid 47555067)
5. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203-205
6. Cohen AT, Agnelli G, Anderson FA et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764 (Pubitemid 47555066)
7. Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol 2004; 57: 1254-1257 (Pubitemid 39611508)
8. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med 1999; 159: 445-453
9. House of Commons Health Committee report. The prevention of venous thromboembolism in hospitalised patients, 2005. Accessed on 23/03/08 from http://www.parliament.the-stationeryoffice.co.uk/pa/cm200405/cmselect/cmhealth/ 99/99.pdf
10. Fratantoni J, Wessler S. Prophylactic therapy of deep vein thrombosis and pulmonary embolism. DHEW: (NIH) 76-866, Washington, DC: US Government Printing Office, 1975.
11. Steier KJ, Singh G, Ullah A, Maneja J, Ha RS, Khan F. Venous thromboembolism: application and effectiveness of the American College of Chest Physicians 2001 guidelines for prophylaxis. J Am Osteopath Assoc 2006; 106: 388-395
12. South A, Iveson E, Allgar V, Harbison J. Geriatrics Registrars Research and Audit Network Yorkshire. The under use of thromboprophylaxis in older medical in-patients: a regional audit. QJM 2007; 100: 685-689 (Pubitemid 350042429)
13. Cohen AT, Tapson VF, Bergmann JF et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371 (9610): 387-394
14. NICE Clinical Guidance. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients having surgery. Accessed on 17/1/08 from www.nice.org.uk/nicemedia/pdf/VTEFullGuide.pdf
15. Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793-800.
16. Desjardins L, Bara L, Boutitie F et al. Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study. Arch Pathol Lab Med 2004; 128: 519-526 (Pubitemid 38579588)
17. Berges A, Laporte S, Epinat M et al. Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years old. Br J Clin Pharmacol 2007; 64: 428-438 (Pubitemid 47404307)
18. Lamy A, Wang X, Kent R, Smith KM, Gafni A. Economic evaluation of the MEDENOX trial: a Canadian perspective. Medical Patients with Enoxaparin. Can Respir J 2002; 9: 169-177
19. Kucher N, Leizorovicz A, Vaitkus PT et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med 2005; 165: 341-345 (Pubitemid 40216291)
20. Cohen AT, Davidson BL, Gallus AS et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006; 332 (7537): 325-329
21. Richards GA, Schoeman HS. Prophylaxis of venous thrombosis in medical patients: A real-world perspective. Cardiovasc J S Afr 2006; 17: 251-254 (Pubitemid 46089128)
22. Kucher N, Koo S, Quiroz R et al. Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med 2005; 352: 969-977 (Pubitemid 40349499)
23. Ageno W, Turpie AG. Clinical trials of deep vein thrombosis prophylaxis in medical patients. Clin Cornerstone 2005; 7: 16-22. (Pubitemid 44296076)
24. Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis. J Intern Med 2008; 263: 52-60. (Pubitemid 350243550)
25. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2007; 167: 1476-1486 (Pubitemid 47124178)
26. Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Clin Ther 2007; 29: 2395-2405
27. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146: 278-288 (Pubitemid 351650614)
28. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiat 2003; 74: 317-321 (Pubitemid 36259354)
29. André C, de Freitas GR, Fukujima MM. Prevention of deep venous thrombosis and pulmonary embolism following stroke: a systematic review of published articles. Eur J Neurol 2007; 14: 21-32. (Pubitemid 46088032)
30. Kelly J, Rudd T, Lewis RR, Hunt BJ. Mortality from pulmonary embolism after acute stroke: can we do better? Age Ageing 2002; 31: 159-161 (Pubitemid 34591389)
31. Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999; 53: 1319-1327
32. Mazzone C, Chiodo GF, Sandercock P, Miccio M, Salvi R. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev 2004 Oct 18; (4): CD001922.
33. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl): 483-512S. (Pubitemid 39297962)
34. Stein PD, Beemath A, Meyers FA, Olson RE. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease. J Cardiovasc Med (Hagerstown) 2007; 8: 253-257 (Pubitemid 46586662)
35. Schönhofer B, Köhler D. Relevance of deep venous thrombosis of the leg in patients with acute exacerbated COPD. Pneumologie 1999; 53: 10-14. (Pubitemid 29070596)
36. Shetty R, Seddighzadeh A, Piazza G, Goldhaber SZ. Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis 2008; 26: 35-40.
37. Siddique RM, Siddique MI, Connors AF Jr, Rimm AA. Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med 1996; 156: 2343-2347 (Pubitemid 26395548)
38. López-Jiménez L, Montero M, González-Fajardo JA et al. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE). Haematologica 2006; 91: 1046-1051 (Pubitemid 44204770)
39. Masotti L, Ceccarelli E, Forconi S, Cappelli R. [Diagnostic and therapeutic features of pulmonary embolism in elderly patients] Ital Heart J Suppl 2003; 4: 745-754
40. Sohne M, Kruip MJ, Nijkeuter M et al. Accuracy of clinical decision rule, D-dimer and spiral computed tomography in patients with malignancy, previous venous thromboembolism, COPD or heart failure and in older patients with suspected pulmonary embolism. J Thromb Haemost 2006; 4: 1042-1046
41. Antonelli F, Villani L, Masotti L, Landini G. Ruling out the diagnosis of venous thromboembolism in the elderly: is it time to revise the role of D-dimer? Am J Emerg Med 2007; 25: 727-728 (Pubitemid 46994736)
42. Modesto-Alapont M, Nauffal-Manzur D, Ansótegui-Barrera E et al. Can home prophylaxis for venous thromboembolism reduce mortality rates in patients with chronic obstructive pulmonary disease? Arch Bronconeumol 2006; 42: 130-134
43. Sellier E, Labarere J, Bosson JL et al. Effectiveness of a guideline for venous thromboembolism prophylaxis in elderly post-acute care patients: a multicenter study with systematic ultrasonographic examination. Arch Intern Med 2006; 166: 2065-2071 (Pubitemid 44631393)
44. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am 2000; 82-A: 929-938 (Pubitemid 30451931)
45. Hull RD, Raskob GE, Pineo GF et al. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. Arch Intern Med 1997; 157: 298-303.
46. Young T, Tang H, Aukes J, Hughes R. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database Syst Rev 2007; (3): CD006212.
47. Review. Update in: Cochrane Database Syst Rev 2007; (4): CD006212.
48. Baglin TP, Keeling DM, Watson HG and the British Committee for Standards in Haematology. Guidelines on oral anticoagulation (warfarin): 3rd edition, 2005 update. Br J Haematol 2006; 132, 277-285.
49. Guidelines on oral anticoagulation: 3rd edition. Br J Haematol 1998; 101: 374-387
50. Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ 2007; 334 (7595): 674.
51. BTS Guidelines for the Management of Suspected Acute Pulmonary Embolism, 2003. The British Thoracic Society Standards of Care Committee, Pulmonary Embolism Guideline Development Group. Thorax 2003; 48: 470-484
52. Eikelboom JW, Ginsberg JS, Hirsh J. Anticoagulation for venous thromboembolism. BMJ 2007; 334 (7595): 645.
53. Othieno R, Abu Affan M, Okpo E. Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev 2007; (3): CD003076. (Pubitemid 351805510)
54. Van Der Heijden JF, Hutten BA, Buller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev 2002; (1): CD002001.
55. Winter M, Keeling D, Sharpen F, Cohen H, Vallance P; Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Procedures for the outpatient management of patients with deep venous thrombosis. Clin Lab Haematol 2005; 27: 61-66
56. Almahameed A, Carman TL. Outpatient management of stable acute pulmonary embolism: proposed accelerated pathway for risk stratification. Am J Med 2007; 120 (10 suppl. 2): S18-25.
57. Fennerty A, Dolben J, Thomas P et al. Flexible induction dose regimen for warfarin and prediction of maintenance dose. Br Med J (Clin Res Ed) 1984; 288 (6426): 1268-1270 (Pubitemid 14117132)
58. Cosh DG, Moritz CK, Ashman KJ, Dally RJ, Gallus AS. Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose. Aust N Z J Med 1989; 19: 191-197
59. Siguret V, Gouin I, Debray M et al. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen. Am J Med 2005; 118: 137-142 (Pubitemid 40202860)
60. van Leeuwen Y, Rombouts EK, Kruithof CJ, Van Der Meer FJ, Rosendaal FR. Improved control of oral anticoagulant dosing: a randomized controlled trial comparing two computer algorithms. J Thromb Haemost 2007; 5: 1644-1649
61. Palareti G, Leali N, Coccheri S et al. Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy) G Ital Cardiol 1997; 27: 231-243 (Pubitemid 27201751)
62. Berwaerts J, Webster J. Analysis of risk factors involved in oral-anticoagulant-related intracranial haemorrhages. QJM 2000; 93: 513-521 (Pubitemid 30623787)
63. Cantalapiedra A, Gutierrez O, Tortosa JI et al. Oral anticoagulant treatment: risk factors involved in 500 intracranial hemorrhages. J Thromb Thrombolysis 2006; 22: 113-120 (Pubitemid 44473561)
64. Fiore LD, Scola MA, Cantillon CE, Brophy MT. Anaphylactoid reactions to vitamin K. J Thromb Thrombolysis 2001; 11: 175-183
65. Pereira SP, Williams R. Adverse events associated with vitamin K1: results of a worldwide postmarketing surveillance programme. Pharmacoepidemiol Drug Saf 1998; 7: 173-182 (Pubitemid 28335356)
66. Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med 2001; 135: 393-400. (Pubitemid 32845864)
67. Routledge PA, Chapman PH, Davies DM, Rawlins MD. Factors affecting warfarin requirements - a prospective population study. Eur J Clin Pharmac 1979; 15: 319-322
68. Routledge PA, Chapman PH, Davies DM, Rawlins MD. Pharmacokinetics and pharmacodynamics of warfarin at steady state. Br J Clin Pharmacol 1979; 8: 243-247
69. British Thoracic Society Guidelines for the management of suspected acute pulmonary embolism. Thorax 2003; 58: 470-474
70. Leacche M, Unic D, Goldhaber SZ et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005; 129: 1018-1023 (Pubitemid 40631421)
71. Gross PL, Weitz JI. New anticoagulants for treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol 2008; 28: 380-386
72. Eriksson BI, Borris LC, Friedman RJ et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 2008; 358: 2765-2775 (Pubitemid 351930851)
73. Lassen MR, Ageno W, Borris LC et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med 2008; 358: 2776-2786 (Pubitemid 351930852)
74. Buller HR, Lensing AW, Prins MH et al. A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study. Blood 2008; 112: 2242-2247
75. Venous thromboembolism - rivaroxaban. NICE technology appraisal. Accessed on 22/01/09 from: http://www.nice.org.uk/Guidance/TA/Wave17/15
76. Pradaxa. EPARs for authorized medicinalproducts for human use. EMEA. Accessed on 17/05/08 from: http://www.emea.europa.eu/humandocs/Humans/EPAR/ pradaxa/pradaxa.htm
77. TA157 Venous thromboembolism - dabigatran: guidance. NICE technology appraisal. Accessed on 22/01/09 from: http://www.nice.org.uk/guidance/index.jsp? action=download&o=42033